tryptoline has been researched along with warfarin in 1 studies
| Studies (tryptoline) | Trials (tryptoline) | Recent Studies (post-2010) (tryptoline) | Studies (warfarin) | Trials (warfarin) | Recent Studies (post-2010) (warfarin) |
|---|---|---|---|---|---|
| 222 | 1 | 69 | 36,573 | 2,143 | 14,728 |
| Protein | Taxonomy | tryptoline (IC50) | warfarin (IC50) |
|---|---|---|---|
| Vitamin K epoxide reductase complex subunit 1 | Homo sapiens (human) | 0.0088 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, N; Futamura, Y; Hayase, H; Honma, T; Kamisaka, K; Kikuzato, K; Kobayashi, F; Koyama, H; Niikura, M; Osada, H; Shimizu, T; Takaya, D; Watanabe, N; Yuki, H | 1 |
1 other study(ies) available for tryptoline and warfarin
| Article | Year |
|---|---|
New antimalarials identified by a cell-based phenotypic approach: Structure-activity relationships of 2,3,4,9-tetrahydro-1H-β-carboline derivatives possessing a 2-((coumarin-5-yl)oxy)alkanoyl moiety.
Topics: Animals; Antimalarials; Carbolines; Coumarins; Mice; Structure-Activity Relationship | 2022 |